Search Medical Condition
Please enter condition
Please choose location

Meerbusch, Germany Clinical Trials

A listing of Meerbusch, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (126) clinical trials

Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto Respimat (AERIAL )

The objective of this NIS is to measure changes in health status including functional status using CCQ scores in COPD patients receiving treatment with Spiolto® Respimat® according to label after approximately 6 weeks in routine clinical practice. In visit 1, patient data on demographics, smoking status, medical history, breathlessness, general ...

Phase N/A

2.53 miles

Learn More »

Explorative Assessment of Biomarkers in Overweight and Obese Subjects

The pre-screening assessments are designed to characterize the metabolic risk profile / prediabetic status in an unselected population of overweight and obese volunteers, aiming to pre-select high risk and prediabetic subjects as a target population who may specifically profit from primary diabetes intervention (prevention) strategies.

Phase N/A

3.04 miles

Learn More »

Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses When Utilizing a Multiple Waveform Enabled Neurostimulator

To evaluate sustainable pain control utilizing the Prodigy or Proclaim Elite family of neurostimulators using a tonic or BurstDR waveform. Subjects will be enrolled prior to their device trial evaluation period. Once the subject has their permanent system implant, they will return to the clinic for follow up visits at ...

Phase N/A

3.04 miles

Learn More »

A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique in Patients With Type 1 Diabetes Mellitus

The study duration per patient will be 18 to 62 days and will consist of a 4 to 28 days of screening period, a treatment period of 2 days, a washout between dosing occasions of 5-18 days, and follow up visit 7-14 days after last dosing.

Phase

3.04 miles

Learn More »